Cite
van der Laan A, Hirsch A, Nijveldt R, et al. Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results. Neth Heart J. 2008;16(12):436-9doi: 10.1007/BF03086194.
van der Laan, A., Hirsch, A., Nijveldt, R., van der Vleuten, P. A., van der Giessen, W. J., Doevendans, P. A., Waltenberger, J., Ten Berg, J. M., Aengevaeren, W. R., Zwaginga, J. J., Biemond, B. J., van Rossum, A. C., Tijssen, J. G., Zijlstra, F., & Piek, J. J. (2008). Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 16(12), 436-9. https://doi.org/10.1007/BF03086194
van der Laan, A, et al. "Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 16,12 (2008): 436-9. doi: https://doi.org/10.1007/BF03086194
van der Laan A, Hirsch A, Nijveldt R, van der Vleuten PA, van der Giessen WJ, Doevendans PA, Waltenberger J, Ten Berg JM, Aengevaeren WR, Zwaginga JJ, Biemond BJ, van Rossum AC, Tijssen JG, Zijlstra F, Piek JJ. Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results. Neth Heart J. 2008 Dec;16(12):436-9. doi: 10.1007/BF03086194. PMID: 19127324; PMCID: PMC2612115.
Copy
Download .nbib